TD Cowen analyst Dan Brennan lowered the firm’s price target on Avantor to $21 from $23 and keeps a Market Perform rating on the shares. The firm noted they posted a largely in line 3Q and while 4Q margin/EPS guide disappointed the messaging versus 2Q was consistent with Bioprocess inventories closer to normal signs of green shoots and broader trends intact.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AVTR: